18F-labeled nAChR antagonists (University of California Irvine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name18F-labeled nAChR antagonists (University of California Irvine)
Drug Alias Name18F-nifrolene18F-nifzetidine18F-nifrolidine18F-labeled nicotinic acetylcholine receptor antagonists (University of California Irvine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of California Irvine
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A